The largest study to correlate genetics with response to cancer drugs releases its first results. The researchers behind the study describe in this initial dataset the responses of 350 cancer samples to 18 anticancer therapeutics. These first results will help cancer researchers around the world to seek better understanding of cancer genetics and could help to improve treatment regimens.